Martin Worley Group’s KalVista Pharmaceuticals KALV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$115K Hold
10,168
0.06% 90
2025
Q1
$117K Hold
10,168
0.07% 81
2024
Q4
$86.1K Buy
+10,168
New +$86.1K 0.05% 85